Comparison of Different Symptom Assessment Scales for Multiple System Atrophy.

作者: Masaaki Matsushima , Ichiro Yabe , Koji Oba , Ken Sakushima , Yasunori Mito

DOI: 10.1007/S12311-015-0686-4

关键词:

摘要: To identify the most sensitive scale for use in clinical trials on multiple system atrophy (MSA), a short and is needed MSA trials. Potential candidates are Unified Rating Scale (UMSARS), Assessment of Ataxia (SARA), Berg Balance (BBS), Health-Related Quality Life (MSA-QoL), Scales Outcomes Parkinson’s Disease–Autonomic questionnaire (SCOPA-AUT). We enrolled patients with from eight hospitals Hokkaido, Japan. Board-certified neurologists assessed each patient at 6-month intervals scored them UMSARS, SARA, BBS, MSA-QoL, SCOPA-AUT. Score changes were evaluated using standardized response mean (SRM). The correlation between disease duration score was examined. first evaluation conducted 85 (60 cerebellar ataxia dominant subtype [MSA-C] 25 Parkinsonism-dominant [MSA-P]). Sixty-nine examined after 6 months 63 12 months. UMSARS Part 4 had largest SRM SARA SRMs MSA-P, shorter group, early-onset group larger than those MSA-C, longer late-onset group. items regarding skilled hand activities, walking, standing relatively large. Our study indicates that (parts 2 4), BBS scales evaluating progression over Items large effectively short-term changes.

参考文章(45)
Sherwin Fs, Keith Ra, Granger Cv, Hamilton Bb, The functional independence measure : a new tool for rehabilitation Advances in clinical rehabilitation. ,vol. 1, pp. 6- 18 ,(1987)
T. Schmitz-Hubsch, S. T. du Montcel, L. Baliko, J. Berciano, S. Boesch, C. Depondt, P. Giunti, C. Globas, J. Infante, J. -S. Kang, B. Kremer, C. Mariotti, B. Melegh, M. Pandolfo, M. Rakowicz, P. Ribai, R. Rola, L. Schols, S. Szymanski, B. P. van de Warrenburg, A. Durr, T. Klockgether, Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. ,vol. 66, pp. 1717- 1720 ,(2006) , 10.1212/01.WNL.0000219042.60538.92
F Geser, K Seppi, M Stampfer-Kountchev, M Köllensperger, A Diem, JP Ndayisaba, K Ostergaard, E Dupont, A Cardozo, E Tolosa, M Abele, R Dodel, T Klockgether, I Ghorayeb, F Yekhlef, F Tison, C Daniels, F Kopper, G Deuschl, M Coelho, J Ferreira, MM Rosa, C Sampaio, M Bozi, A Schrag, J Hooker, H Kim, T Scaravilli, CJ Mathias, C Fowler, N Wood, N Quinn, Håkan Widner, CF Nilsson, Olle Lindvall, N Schimke, KM Eggert, W Oertel, F Del Sorbo, F Carella, A Albanese, Maria Teresa Pellecchia, Paolo Barone, R Djaldetti, Giuseppe Meco, Carlo Colosimo, A Gonzalez-Mandly, J Berciano, T Gurevich, N Giladi, M Galitzky, F Ory, O Rascol, C Kamm, K Buerk, S Maass, T Gasser, W Poewe, GK Wenning, EMSA-SG, None, The European Multiple System Atrophy-Study Group (EMSA-SG) Journal of Neural Transmission. ,vol. 112, pp. 1677- 1686 ,(2005) , 10.1007/S00702-005-0328-Y
Susanne May, Sid Gilman, B Brooke Sowell, Ronald G Thomas, Matthew B Stern, Amy Colcher, Caroline M Tanner, Neng Huang, Peter Novak, Stephen G Reich, Joseph Jankovic, William G Ondo, Phillip A Low, Paola Sandroni, Axel Lipp, Frederick J Marshall, Frederick Wooten, Clifford W Shults, North American Multiple System Atrophy Study Group, Potential outcome measures and trial design issues for multiple system atrophy Movement Disorders. ,vol. 22, pp. 2371- 2377 ,(2007) , 10.1002/MDS.21734
Gregor K Wenning, Felix Geser, Florian Krismer, Klaus Seppi, Susanne Duerr, Sylvia Boesch, Martin Köllensperger, Georg Goebel, Karl P Pfeiffer, Paolo Barone, Maria Teresa Pellecchia, Niall P Quinn, Vasiliki Koukouni, Clare J Fowler, Anette Schrag, Christopher J Mathias, Nir Giladi, Tanya Gurevich, Erik Dupont, Karen Ostergaard, Christer F Nilsson, Håkan Widner, Wolfgang Oertel, Karla Maria Eggert, Alberto Albanese, Francesca Del Sorbo, Eduardo Tolosa, Adriana Cardozo, Günther Deuschl, Helge Hellriegel, Thomas Klockgether, Richard Dodel, Cristina Sampaio, Miguel Coelho, Ruth Djaldetti, Eldad Melamed, Thomas Gasser, Christoph Kamm, Giuseppe Meco, Carlo Colosimo, Olivier Rascol, Wassilios G Meissner, François Tison, Werner Poewe, None, The natural history of multiple system atrophy: a prospective European cohort study Lancet Neurology. ,vol. 12, pp. 264- 274 ,(2013) , 10.1016/S1474-4422(12)70327-7
Katherine Berg, Measuring balance in the elderly: preliminary development of an instrument Physiotherapy Canada. ,vol. 41, pp. 304- 311 ,(1989) , 10.3138/PTC.41.6.304
Wassilios G Meissner, Alexandra Foubert‐Samier, Sandrine Dupouy, Angélique Gerdelat‐Mas, Rachel Debs, Fabienne Marquant, Valérie Cochen De Cock, Olivier Rascol, François Tison, Anne Pavy‐Le Traon, None, Assessment of quality of life with the multiple system atrophy health‐related quality of life scale Movement Disorders. ,vol. 27, pp. 1574- 1577 ,(2012) , 10.1002/MDS.25174
Hirohisa Watanabe, Yufuko Saito, Shinichi Terao, Tetsuo Ando, Teruhiko Kachi, Eiichiro Mukai, Ikuko Aiba, Yuji Abe, Akiko Tamakoshi, Manabu Doyu, Masaaki Hirayama, Gen Sobue, Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain. ,vol. 125, pp. 1070- 1083 ,(2002) , 10.1093/BRAIN/AWF117
Phillip A Low, David Robertson, Sid Gilman, Horacio Kaufmann, Wolfgang Singer, Italo Biaggioni, Roy Freeman, Susan Perlman, Robert A Hauser, William Cheshire, Stephanie Lessig, Steven Vernino, Jay Mandrekar, William D Dupont, Thomas Chelimsky, Wendy R Galpern, Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial Lancet Neurology. ,vol. 13, pp. 268- 275 ,(2014) , 10.1016/S1474-4422(13)70301-6